Nourish
WhatsApp

About

Committed to
Nourishing Life

Since its founding in 2013, Nourish Pharmaceutical Pvt. Ltd. has been committed to manufacturing high-quality pharmaceutical products that improve lives and strengthen healthcare systems across global markets. Through advanced manufacturing capabilities, stringent quality standards, and a customer-centric approach, we continue to deliver trusted pharmaceutical solutions to healthcare partners worldwide. Over the years, Nourish has grown into a trusted pharmaceutical manufacturer serving healthcare partners across Africa, the Middle East, Southeast Asia, Latin America, and other emerging international markets.

With a diversified portfolio of more than 200 pharmaceutical products, we manufacture and supply a comprehensive range of dosage forms, including tablets, capsules, oral liquids, dry syrups, injectables, infusions, topical formulations, nasal sprays, and other specialized pharmaceutical products. Our portfolio spans multiple therapeutic segments, including Anti-Hypertensives, Anti-Diabetics, Lipid-Lowering Agents, Anti-Infectives, Antibiotics, Respiratory Care, Haematinics, Anti-Allergic, Pain Management, Gastrointestinal Care, and Vitamin & Nutritional Supplements, with particular expertise in chronic care therapies. Through our unwavering commitment to quality, regulatory compliance, innovation, and dependable supply, we have built lasting partnerships with pharmaceutical companies, distributors, healthcare organizations, NGOs, and government institutions worldwide.

0+

Years of Excellence

0+

Product Portfolio

0+

Export Markets

Raising the Standard of Manufacturing

Driven by continuous improvement and manufacturing excellence, we combine modern technology, experienced professionals, and robust quality systems to ensure every product consistently meets international quality standards. As we continue to expand our presence across global markets, we remain dedicated to delivering safe, effective, and affordable pharmaceutical solutions while staying true to our promise.

Accreditations

WHO

WHO

ISO

ISO

Kenya

Kenya

Myanmar

Myanmar

Cambodia

Cambodia

Afghanistan

Afghanistan

Zambia

Zambia

Iraq (upcoming)

Iraq (upcoming)

Sudan (upcoming)

Sudan (upcoming)

Nourish Pharmaceutical Pvt. Ltd.issteadfastinitscommitmenttonourishinglifethroughexcellenceinpharmaceuticalmanufacturing.

Ourvisionistobealeaderinprovidingsuperiorcontractmanufacturingandresearch&developmentsolutionstotop-tierpharmaceuticalcompaniesglobally.Weaspiretopioneerinnovationsthatsetindustrystandardsforqualityandsustainability.

Quality

Quality

We relentlessly pursue excellence in all aspects of our operations, ensuring that every department adheres to uncompromising standards of quality.

Integrity

Integrity

We uphold the highest ethical standards in service delivery, stakeholder engagement, and corporate governance, fostering a culture of transparency and trust.

Commitment

Commitment

Our dedicated teams are focused on fulfilling your project and supply demands with precision and consistency, adhering to the highest industry standards.

Customer Satisfaction

Customer Satisfaction

We deeply value their partnership and commit to continuously surpassing their expectations, enhancing customer satisfaction through every interaction.

Our Journey

Our Journey

2023
19
2023

Launch of State-of-the-Art Manufacturing Facility for Tablets, Capsules, and Liquid Orals

Opened a state-of-the-art manufacturing plant compliant with global standards for tablets, capsules, and liquid orals.

2019

Production Capacity Boosted to 70% Through Domestic Expansion

Increased production capacity to 70% through significant domestic expansion.

September 2023

Launch of State-of-the-Art Manufacturing Facility for Tablets, Capsules, and Liquid Orals

June 2019

Production Capacity Boosted to 70% Through Domestic Expansion

March 2017

Launch of Small-Scale Plant Boosts Tablet and Liquid Oral Production Efficiency

January 2015

International R&D Center Establishment

November 2010

Company Inception and Initial Infrastructure